Compound Ammonium + Glycyrrhetate and Sodium Chloride Injection Glass Bottle

• Customization: Available
• Medicine: Large Volume Injection
• Production Line: GMP Approved
• Model NO.: 100ml
• Transport Package: Carton
• Specification: 100ml*80
• Trademark: SHIMEN
• Origin: Hebei
• HS Code: 3004909099
• Production Capacity: 1000000bottles

Product Description

Compound Ammonium + Glycyrrhetate and Sodium Chloride Injection

Name: Compound  Ammonium + Glycyrrhetate and Sodium Chloride Injection

Pharmaceutics: Liver auxiliary treatment drug.


Shijiazhuang No.4 Pharmaceutical Co., Ltd. was established in 1948, now it is a large-sized civilian-run public share holding and comprehensive medicine manufacturer in China, the capital is USD14 million, and with more than 3000 employees. The company can manufacture 7 series medicines of more than 100 kinds and specifications including infusions, capsules, granules, tablets, oral liquids and etc with GMP approval by SFDA of China. For the key product of large volume I.V solution, the yearly output has reached more than 100 million bottles including 40 million bottles packing with the soft plastic bottles in the dosage of 500 ml/ 250 ml /100ml. Some index such as quality, variety, and yearly output are all in the leading position of this field in China.  
The products have been sold to some countries and regions in South America, Africa, and Asia.
 

Product Name	Package
Compound Ammonium + Glycyrrhetate and Sodium Chloride Injection	100ml glass bottle

Shijiazhuang No. 4 Pharmaceutical Co., Ltd., as one of the leading manufacturers in Chinese pharmaceutical industry and a well-known brand, has a business history of seventy years. The company principally specializes in R & D, manufacture and sales of wide types of drugs mainly including intravenous infusion.
The production lines have achieved full automation control and information control in the production process and logistics process and reached international advanced level by integrating the world's leading equipment and technology.
With product quality as its life, the Company always organizes production in strict accordance with GMP requirements, establishes and implements superior service concepts and measures and provides guarantee for the health of the majority of patients at home and abroad with excellent quality products and services.
The Company has a powerful R&D team and made a number of achievements in scientific research and undertaken many major scientific and technological innovation projects and industrialization projects by firmly grasping the pulse of pharmaceutical development, increasing new product development investment and accelerating the pace of technological innovation.
Large volume injection is the key products, tablets, capsules, small volume injection and other forms are manufactured also. Recently API has been put into production and sales. There are more than ten international advanced production lines for the large volume injection, its production scale, technology level, brand influence and economic benefit are on the forefront of domestic counterparts, and it has become one of China's top 100 pharmaceutical industry enterprises and China's top 10 chemical and pharmaceutical industry preparation export-oriented excellent enterprise brands for many consecutive years.
The products are radiated to all provinces, autonomous regions and municipalities in China and also exported to many overseas markets, including more than 80 countries in Asia, Americas, Europe, Oceania, Africa and other continents, and it has become one of the main export enterprises of infusion products.